View in EDS

Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non-Small-Cell Lung Cancer in CheckMate 227.

Saved in:
Bibliographic Details
Title: Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non-Small-Cell Lung Cancer in CheckMate 227.
Authors: Brahmer JR; Johns Hopkins Kimmel Cancer Center, Baltimore, MD., Lee JS; National University Bundang Hospital, Seongnam, Republic of Korea., Ciuleanu TE; Institutul Oncologic Prof Dr Ion Chiricuta and University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania., Bernabe Caro R; Hospital Universitario Virgen Del Rocio, Instituto de Biomedicina de Seville, Seville, Spain., Nishio M; Department of Thoracic Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan., Urban L; Matrai Gyogyintezet, Mátraháza, Hungary., Audigier-Valette C; Orientation Oncologique, Hôpital Sainte Musse, Toulon, France., Lupinacci L; Hospital Italiano De Buenos Aires, Buenos Aires, Argentina., Sangha R; Cross Cancer Institute, Edmonton, AB, Canada., Pluzanski A; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Burgers J; Netherlands Cancer Institute, Amsterdam, the Netherlands., Mahave M; Instituto Oncológico Fundación Arturo López Pérez, Santiago, Chile., Ahmed S; University Hospitals of Leicester NHS Trust, Infirmary Square, Leicester, United Kingdom., Schoenfeld AJ; Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY., Paz-Ares LG; Hospital Universitario 12 de Octubre, H12O-CNIO Lung Cancer Clinical Research Unit, Universidad Complutense & CiberOnc, Madrid, Spain., Reck M; Airway Research Center North, German Center for Lung Research, Lung Clinic, Grosshansdorf, Germany., Borghaei H; Fox Chase Cancer Center, Philadelphia, PA., O'Byrne KJ; Princess Alexandra Hospital, Translational Research Institute and Queensland University of Technology, Brisbane, Queensland, Australia., Gupta RG; Bristol Myers Squibb, Princeton, NJ., Bushong J; Bristol Myers Squibb, Princeton, NJ., Li L; Bristol Myers Squibb, Princeton, NJ., Blum SI; Bristol Myers Squibb, Princeton, NJ., Eccles LJ; Bristol Myers Squibb, Princeton, NJ., Ramalingam SS; Winship Cancer Institute, Emory University, Atlanta, GA.
Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Feb 20; Vol. 41 (6), pp. 1200-1212. Date of Electronic Publication: 2022 Oct 12.
Publication Type: Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36223558
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non-Small-Cell Lung Cancer in CheckMate 227.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Brahmer+JR%22">Brahmer JR</searchLink>; Johns Hopkins Kimmel Cancer Center, Baltimore, MD.<br /><searchLink fieldCode="AU" term="%22Lee+JS%22">Lee JS</searchLink>; National University Bundang Hospital, Seongnam, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Ciuleanu+TE%22">Ciuleanu TE</searchLink>; Institutul Oncologic Prof Dr Ion Chiricuta and University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania.<br /><searchLink fieldCode="AU" term="%22Bernabe+Caro+R%22">Bernabe Caro R</searchLink>; Hospital Universitario Virgen Del Rocio, Instituto de Biomedicina de Seville, Seville, Spain.<br /><searchLink fieldCode="AU" term="%22Nishio+M%22">Nishio M</searchLink>; Department of Thoracic Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Urban+L%22">Urban L</searchLink>; Matrai Gyogyintezet, Mátraháza, Hungary.<br /><searchLink fieldCode="AU" term="%22Audigier-Valette+C%22">Audigier-Valette C</searchLink>; Orientation Oncologique, Hôpital Sainte Musse, Toulon, France.<br /><searchLink fieldCode="AU" term="%22Lupinacci+L%22">Lupinacci L</searchLink>; Hospital Italiano De Buenos Aires, Buenos Aires, Argentina.<br /><searchLink fieldCode="AU" term="%22Sangha+R%22">Sangha R</searchLink>; Cross Cancer Institute, Edmonton, AB, Canada.<br /><searchLink fieldCode="AU" term="%22Pluzanski+A%22">Pluzanski A</searchLink>; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.<br /><searchLink fieldCode="AU" term="%22Burgers+J%22">Burgers J</searchLink>; Netherlands Cancer Institute, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Mahave+M%22">Mahave M</searchLink>; Instituto Oncológico Fundación Arturo López Pérez, Santiago, Chile.<br /><searchLink fieldCode="AU" term="%22Ahmed+S%22">Ahmed S</searchLink>; University Hospitals of Leicester NHS Trust, Infirmary Square, Leicester, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Schoenfeld+AJ%22">Schoenfeld AJ</searchLink>; Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY.<br /><searchLink fieldCode="AU" term="%22Paz-Ares+LG%22">Paz-Ares LG</searchLink>; Hospital Universitario 12 de Octubre, H12O-CNIO Lung Cancer Clinical Research Unit, Universidad Complutense & CiberOnc, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Reck+M%22">Reck M</searchLink>; Airway Research Center North, German Center for Lung Research, Lung Clinic, Grosshansdorf, Germany.<br /><searchLink fieldCode="AU" term="%22Borghaei+H%22">Borghaei H</searchLink>; Fox Chase Cancer Center, Philadelphia, PA.<br /><searchLink fieldCode="AU" term="%22O'Byrne+KJ%22">O'Byrne KJ</searchLink>; Princess Alexandra Hospital, Translational Research Institute and Queensland University of Technology, Brisbane, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Gupta+RG%22">Gupta RG</searchLink>; Bristol Myers Squibb, Princeton, NJ.<br /><searchLink fieldCode="AU" term="%22Bushong+J%22">Bushong J</searchLink>; Bristol Myers Squibb, Princeton, NJ.<br /><searchLink fieldCode="AU" term="%22Li+L%22">Li L</searchLink>; Bristol Myers Squibb, Princeton, NJ.<br /><searchLink fieldCode="AU" term="%22Blum+SI%22">Blum SI</searchLink>; Bristol Myers Squibb, Princeton, NJ.<br /><searchLink fieldCode="AU" term="%22Eccles+LJ%22">Eccles LJ</searchLink>; Bristol Myers Squibb, Princeton, NJ.<br /><searchLink fieldCode="AU" term="%22Ramalingam+SS%22">Ramalingam SS</searchLink>; Winship Cancer Institute, Emory University, Atlanta, GA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228309333%22">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</searchLink> [J Clin Oncol] 2023 Feb 20; Vol. 41 (6), pp. 1200-1212. <i>Date of Electronic Publication: </i>2022 Oct 12.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Clinical+Oncology%22">American Society of Clinical Oncology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8309333 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1527-7755 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220732183X%22">0732183X </searchLink><i>NLM ISO Abbreviation: </i>J Clin Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36223558
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1200/JCO.22.01503
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1200
    Titles:
      – TitleFull: Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non-Small-Cell Lung Cancer in CheckMate 227.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Brahmer JR
      – PersonEntity:
          Name:
            NameFull: Lee JS
      – PersonEntity:
          Name:
            NameFull: Ciuleanu TE
      – PersonEntity:
          Name:
            NameFull: Bernabe Caro R
      – PersonEntity:
          Name:
            NameFull: Nishio M
      – PersonEntity:
          Name:
            NameFull: Urban L
      – PersonEntity:
          Name:
            NameFull: Audigier-Valette C
      – PersonEntity:
          Name:
            NameFull: Lupinacci L
      – PersonEntity:
          Name:
            NameFull: Sangha R
      – PersonEntity:
          Name:
            NameFull: Pluzanski A
      – PersonEntity:
          Name:
            NameFull: Burgers J
      – PersonEntity:
          Name:
            NameFull: Mahave M
      – PersonEntity:
          Name:
            NameFull: Ahmed S
      – PersonEntity:
          Name:
            NameFull: Schoenfeld AJ
      – PersonEntity:
          Name:
            NameFull: Paz-Ares LG
      – PersonEntity:
          Name:
            NameFull: Reck M
      – PersonEntity:
          Name:
            NameFull: Borghaei H
      – PersonEntity:
          Name:
            NameFull: O'Byrne KJ
      – PersonEntity:
          Name:
            NameFull: Gupta RG
      – PersonEntity:
          Name:
            NameFull: Bushong J
      – PersonEntity:
          Name:
            NameFull: Li L
      – PersonEntity:
          Name:
            NameFull: Blum SI
      – PersonEntity:
          Name:
            NameFull: Eccles LJ
      – PersonEntity:
          Name:
            NameFull: Ramalingam SS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 20
              M: 02
              Text: 2023 Feb 20
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1527-7755
          Numbering:
            – Type: volume
              Value: 41
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
              Type: main
ResultId 1